YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Pfizer to buy Medivation for $14B

Posted online
Pfizer Inc. penned a deal to purchase biotech company Medivation Inc. for $14 billion.

The $81.50 per share acquisition would give Pfizer access to Xtandi, a drug used to treat prostate cancer.

The deal is expected to close in the third or fourth quarter this year.

Read more from The Wall Street Journal.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Transportation officials discuss $471M Forward 44 initiative

Project work in Springfield corridor will continue into 2031.

Most Read
Update cookies preferences